
CAS 443104-02-7
:28-(1H-Imidazol-1-yl)-3,12,28-trioxooleana-1,9(11)-diene-2-carbonitrile
- CDDO-Im
- CDDO-Imidazolide
- 1-[2-Cyano-3,12,28-trioxooleana-1,9(11)-dien-28-yl]-1H-imidazole
(4Ar,6As,6Br,8As,12As,12Br,14Bs)-8A-(1H-Imidazole-1-Carbonyl)-4,4,6A,6B,11,11,14B-Heptamethyl-3,13-Dioxo-3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Octadecahydropicene-2-Carbonitrile
CAS:(4Ar,6As,6Br,8As,12As,12Br,14Bs)-8A-(1H-Imidazole-1-Carbonyl)-4,4,6A,6B,11,11,14B-Heptamethyl-3,13-Dioxo-3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Octadecahydropicene-2-CarbonitrilePurity:98%Molecular weight:541.72g/molCDDO-Im
CAS:CDDO-Im (TP-235) is an activator of Nrf2 and PPAR (Kis: 232/344 nM for PPARα/PPARγ).Formula:C34H43N3O3Purity:98.3% - 99.61%Color and Shape:SolidMolecular weight:541.72Ref: TM-TQ0120
1mg34.00€5mg74.00€10mg105.00€25mg200.00€50mg319.00€100mg485.00€500mg1,035.00€1mL*10mM (DMSO)89.00€CDDO Imidazolide
CAS:Controlled ProductStability Light Sensitive
Applications CDDO Imidozolide (CDDO-Im) is a synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells. Studies show that CDDO-Im is highly active in suppressing cellular proliferation of human leukemia and breast cancer cell lines as well as being an effective therapeutic agent in the treatment of other types of cancers.
References Hughes, D.T. et al.: Cancer Invest., 26, 118 (2008); Place, A.E. et al.: Clin. Cancer Res., 9, 2798 (2003); Samudio, I. et al.: J. Biol. Chem., 280, 36273 (2005);Formula:C34H43N3O3Color and Shape:NeatMolecular weight:541.72CDDO Im
CAS:CDDO Im is a natural compound that has potent antitumor activity and anti-inflammatory properties. CDDO Im may also be useful in the treatment of inflammatory bowel disease by inhibiting the production of chemokines and inducing apoptosis in colonic epithelial cells. It inhibits the activation of NF-κB, which is a transcription factor that regulates the expression of many genes involved in inflammation, including cytokines and adhesion molecules. CDDO Im also inhibits epidermal growth factor (EGF) signaling and cell proliferation. This compound can also induce apoptosis via reactive oxygen species. CDDO Im has been shown to inhibit the lps-induced inflammatory response by decreasing pro-inflammatory cytokine levels and preventing neutrophil infiltration into the gut mucosa.
Formula:C34H43N3O3Purity:Min. 95%Molecular weight:541.72 g/mol




